Osteoarthritis Injectables Market Size, Share & Trends Analysis Report By Injection Type (Hyaluronic Acid Injections, Corticosteroids Injections), By Anatomy (Knee Osteoarthritis, Hip Osteoarthritis), By End-use, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Osteoarthritis Injectables Market Growth & Trends
The global osteoarthritis injectables market size is anticipated to reach USD 11.42 billion by 2030, exhibiting a CAGR of 6.82% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing growth, influenced by several key factors. Women aged 50 to 60 are more susceptible to developing hand and knee osteoarthritis (OA) compared to men, due to hormonal changes and musculoskeletal differences, as highlighted by Arthritis-health data from January 2021. Additionally, obesity rates, higher among women according to the National Institutes of Health, further increase the risk. In the U.S. alone, it is projected that the number of osteoarthritis patients will reach 70 million by 2040.
The growing geriatric population is a significant driver for market expansion. An NCBI report from May 2023 predicts that the combination of an aging population and obesity will more than double the number of osteoarthritis patients to 67 million by 2030. The majority of cases are expected to occur in individuals aged 65 and above, with 45% of current osteoarthritis patients falling into this age group, according to an OAAA study supported by the CDC in March 2024. This demographic shift impacts productivity, reducing work efficiency and increasing the disease burden.
Research and development activities are also boosting the osteoarthritis injectables market growth, with pharmaceutical companies and research institutes focusing on the development of novel drugs for OA management. BioSenic's announcement in January 2024 regarding the phase 3 study of JTA-004, an innovative treatment for knee OA, demonstrates the industry's commitment to advancing treatment options. Academic and research institutes are also actively involved in developing novel therapies. For instance, a GP130 investigational drug, reported in March 2023, shows promise in managing inflammation and pain. Additionally, Kolon TissueGene, Inc.'s Phase 2 clinical trial for TG-C in hip OA aims to evaluate pain and quality-of-life improvements.
The adoption of oral drugs, surgery, and home remedies such as gin-soaked raisins or wearing copper bracelets for the treatment of OA is expected to adversely affect market growth. The adoption of oral and topical treatment drugs such as analgesics, NSAIDs, and corticosteroids, is increasing due to the patient-centric approach and ease of use. Moreover, increase in research activities to develop novel oral drugs to manage inflammation and pain due to OA is anticipated to hinder the market expansion of OA injectable drugs in the coming years. For instance, in February 2022, Medivir AB published the post-hoc analysis of a randomized phase 2a clinical trial of MIV-711 and its symptomatic and structural benefits for pain management of OA. MIV-711 is an orally administered drug targeting both bone resorption and cartilage degradation.
Osteoarthritis Injectables Market Report Highlights
Osteoarthritis Injectables Market Growth & Trends
The global osteoarthritis injectables market size is anticipated to reach USD 11.42 billion by 2030, exhibiting a CAGR of 6.82% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing growth, influenced by several key factors. Women aged 50 to 60 are more susceptible to developing hand and knee osteoarthritis (OA) compared to men, due to hormonal changes and musculoskeletal differences, as highlighted by Arthritis-health data from January 2021. Additionally, obesity rates, higher among women according to the National Institutes of Health, further increase the risk. In the U.S. alone, it is projected that the number of osteoarthritis patients will reach 70 million by 2040.
The growing geriatric population is a significant driver for market expansion. An NCBI report from May 2023 predicts that the combination of an aging population and obesity will more than double the number of osteoarthritis patients to 67 million by 2030. The majority of cases are expected to occur in individuals aged 65 and above, with 45% of current osteoarthritis patients falling into this age group, according to an OAAA study supported by the CDC in March 2024. This demographic shift impacts productivity, reducing work efficiency and increasing the disease burden.
Research and development activities are also boosting the osteoarthritis injectables market growth, with pharmaceutical companies and research institutes focusing on the development of novel drugs for OA management. BioSenic's announcement in January 2024 regarding the phase 3 study of JTA-004, an innovative treatment for knee OA, demonstrates the industry's commitment to advancing treatment options. Academic and research institutes are also actively involved in developing novel therapies. For instance, a GP130 investigational drug, reported in March 2023, shows promise in managing inflammation and pain. Additionally, Kolon TissueGene, Inc.'s Phase 2 clinical trial for TG-C in hip OA aims to evaluate pain and quality-of-life improvements.
The adoption of oral drugs, surgery, and home remedies such as gin-soaked raisins or wearing copper bracelets for the treatment of OA is expected to adversely affect market growth. The adoption of oral and topical treatment drugs such as analgesics, NSAIDs, and corticosteroids, is increasing due to the patient-centric approach and ease of use. Moreover, increase in research activities to develop novel oral drugs to manage inflammation and pain due to OA is anticipated to hinder the market expansion of OA injectable drugs in the coming years. For instance, in February 2022, Medivir AB published the post-hoc analysis of a randomized phase 2a clinical trial of MIV-711 and its symptomatic and structural benefits for pain management of OA. MIV-711 is an orally administered drug targeting both bone resorption and cartilage degradation.
Osteoarthritis Injectables Market Report Highlights
- Hyaluronic Acid (HA) injections segment dominated the market in 2023, owing to its high prescription rate in OA.
- Knee osteoarthritis segment dominated the market in 2023. Knee OA is a prevalent condition particularly affecting older individuals, with the U.S. witnessing it as the second leading cause of incapacity among men aged 50 years and above.
- Hospital pharmacies segment dominated the market in 2023. Hospital pharmacies play a pivotal role in osteoarthritis management, owing to factors such as higher number of treatments performed in the hospital setting.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Injection Type
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Injection Type
2.2.2. End-use
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of osteoarthritis
3.2.1.2. Growing geriatric population susceptible to osteoarthritis
3.2.1.3. Increase in R&D activities for injectable drug development
3.2.2. Market restraint analysis
3.2.2.1. Adoption of other treatment options
3.2.2.2. High cost of treatment
3.3. Global Osteoarthritis Injectables Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Pricing Analysis
3.3.3. Pricing Analysis
CHAPTER 4. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: INJECTION TYPE ESTIMATES & TREND ANALYSIS
4.1. Injection Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Osteoarthritis Injectables Market by Injection Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Hyaluronic Acid Injections
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Corticosteroid Injections
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Platelet-rich Plasma (PRP) Injections
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Placental Tissue Matrix (PTM) Injections
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Acetylsalicylic Acid (ASA) Injections
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: ANATOMY ESTIMATES & TREND ANALYSIS
5.1. Anatomy Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Osteoarthritis Injectables Market by Anatomy Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Knee Osteoarthritis
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Hip Osteoarthritis
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hand Osteoarthritis
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Osteoarthritis Injectables Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospital Pharmacies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Retail Pharmacies
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY
7.1. Regional Market Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Anika Therapeutics, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Injection Type benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Bioventus.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Injection Type benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Ferring Pharmaceuticals Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Injection Type benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Sanofi S.A.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Injection Type benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Flexion Therapeutics, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Injection Type benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Zimmer Biomet
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Injection Type benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Arthrex, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Injection Type benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Royal Biologics
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Injection Type benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Teva Pharmaceutical Industries Ltd.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Injection Type benchmarking
8.3.12.4. Strategic initiatives
CHAPTER 9. CONCLUSION AND ANALYST PERSPECTIVE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Injection Type
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Injection Type
2.2.2. End-use
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of osteoarthritis
3.2.1.2. Growing geriatric population susceptible to osteoarthritis
3.2.1.3. Increase in R&D activities for injectable drug development
3.2.2. Market restraint analysis
3.2.2.1. Adoption of other treatment options
3.2.2.2. High cost of treatment
3.3. Global Osteoarthritis Injectables Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Pricing Analysis
3.3.3. Pricing Analysis
CHAPTER 4. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: INJECTION TYPE ESTIMATES & TREND ANALYSIS
4.1. Injection Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Osteoarthritis Injectables Market by Injection Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Hyaluronic Acid Injections
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Corticosteroid Injections
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Platelet-rich Plasma (PRP) Injections
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Placental Tissue Matrix (PTM) Injections
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Acetylsalicylic Acid (ASA) Injections
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: ANATOMY ESTIMATES & TREND ANALYSIS
5.1. Anatomy Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Osteoarthritis Injectables Market by Anatomy Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Knee Osteoarthritis
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Hip Osteoarthritis
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hand Osteoarthritis
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Osteoarthritis Injectables Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospital Pharmacies
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Retail Pharmacies
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Others
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. GLOBAL OSTEOARTHRITIS INJECTABLES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY
7.1. Regional Market Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Anika Therapeutics, Inc.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Injection Type benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Bioventus.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Injection Type benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Ferring Pharmaceuticals Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Injection Type benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Sanofi S.A.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Injection Type benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Flexion Therapeutics, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Injection Type benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Zimmer Biomet
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Injection Type benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Arthrex, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Injection Type benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Royal Biologics
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Injection Type benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Teva Pharmaceutical Industries Ltd.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Injection Type benchmarking
8.3.12.4. Strategic initiatives
CHAPTER 9. CONCLUSION AND ANALYST PERSPECTIVE
LIST OF TABLES
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 4 North America Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 5 North America Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 6 North America Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 7 U.S. Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 8 U.S. Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 9 U.S. Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 10 Canada Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 11 Canada Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 12 Canada Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 13 Europe Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 14 Europe Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 15 Europe Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 16 Europe Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 17 Germany Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 18 Germany Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 19 Germany Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 20 UK Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 21 UK Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 22 UK Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 23 France Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 24 France Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 25 France Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 26 Italy Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 27 Italy Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 28 Italy Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 29 Spain Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 30 Spain Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 31 Sapin Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 32 Denmark Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 33 Denmark Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 34 Denmark Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 35 Sweden Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 36 Sweden Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 37 Sweden Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 38 Norway Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 39 Norway Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 40 Norway Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Japan Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 46 Japan Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 47 Japan Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 48 China Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 49 China Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 50 China Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 51 India Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 52 India Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 53 India Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 54 Australia Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 55 Australia Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 56 Australia Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 57 South Korea Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 58 Thailand Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 59 Thailand Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 60 Thailand Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 61 Latin America Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 62 Latin America Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 63 Latin America Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 64 Latin America Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 65 Brazil Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 66 Brazil Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 67 Brazil Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 68 Mexico Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 69 Mexico Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 70 Mexico Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 71 Argentina Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 72 Argentina Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 73 Argentina Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 74 MEA Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 75 MEA Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 76 MEA Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 77 MEA Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 78 South Africa Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 79 South Africa Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 80 South Africa Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 84 UAE Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 85 UAE Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 86 UAE Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 87 Kuwait Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 88 Kuwait Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 89 Kuwait Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 North America Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 4 North America Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 5 North America Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 6 North America Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 7 U.S. Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 8 U.S. Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 9 U.S. Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 10 Canada Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 11 Canada Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 12 Canada Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 13 Europe Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 14 Europe Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 15 Europe Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 16 Europe Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 17 Germany Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 18 Germany Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 19 Germany Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 20 UK Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 21 UK Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 22 UK Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 23 France Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 24 France Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 25 France Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 26 Italy Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 27 Italy Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 28 Italy Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 29 Spain Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 30 Spain Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 31 Sapin Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 32 Denmark Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 33 Denmark Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 34 Denmark Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 35 Sweden Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 36 Sweden Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 37 Sweden Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 38 Norway Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 39 Norway Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 40 Norway Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 45 Japan Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 46 Japan Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 47 Japan Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 48 China Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 49 China Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 50 China Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 51 India Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 52 India Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 53 India Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 54 Australia Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 55 Australia Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 56 Australia Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 57 South Korea Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 58 Thailand Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 59 Thailand Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 60 Thailand Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 61 Latin America Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 62 Latin America Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 63 Latin America Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 64 Latin America Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 65 Brazil Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 66 Brazil Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 67 Brazil Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 68 Mexico Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 69 Mexico Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 70 Mexico Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 71 Argentina Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 72 Argentina Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 73 Argentina Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 74 MEA Osteoarthritis injectables Market, by country, 2018 - 2030 (USD Million)
Table 75 MEA Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 76 MEA Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 77 MEA Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 78 South Africa Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 79 South Africa Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 80 South Africa Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 84 UAE Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 85 UAE Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 86 UAE Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
Table 87 Kuwait Osteoarthritis injectables Market, by Injection Type, 2018 - 2030 (USD Million)
Table 88 Kuwait Osteoarthritis injectables Market, by Anatomy, 2018 - 2030 (USD Million)
Table 89 Kuwait Osteoarthritis injectables Market, by End Use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Global Osteoarthritis Injectables market: market outlook
Fig. 9 Global Osteoarthritis Injectables competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Global Osteoarthritis Injectables market driver impact
Fig. 15 Global Osteoarthritis Injectables market restraint impact
Fig. 16 Global Osteoarthritis Injectables market strategic initiatives analysis
Fig. 17 Global Osteoarthritis Injectables market: Injection Type movement analysis
Fig. 18 Global Osteoarthritis Injectables market: Injection Type outlook and key takeaways
Fig. 19 Hyaluronic Acid Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Corticosteroid Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Platelet-rich Plasma (PRP) Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Placental Tissue Matrix (PTM) Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Acetylsalicylic Acid (ASA) Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Global Osteoarthritis Injectables market: Anatomy movement analysis
Fig. 26 Global Osteoarthritis Injectables market: Anatomy outlook and key takeaways
Fig. 27 Knee Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Hip Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Hand Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Global Osteoarthritis Injectables market: End-use movement analysis
Fig. 32 Global Osteoarthritis Injectables market: End-use outlook and key takeaways
Fig. 33 Hospital Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Retail Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Market share of key market players- Global Osteoarthritis Injectables market
Fig. 37 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 38 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 39 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 40 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 41 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 42 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 43 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 44 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 45 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 46 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 47 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 48 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 49 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 50 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 51 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 52 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 53 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 54 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 55 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 56 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 57 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 58 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 59 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
Fig. 60 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 61 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 62 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 63 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 64 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Global Osteoarthritis Injectables market: market outlook
Fig. 9 Global Osteoarthritis Injectables competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Global Osteoarthritis Injectables market driver impact
Fig. 15 Global Osteoarthritis Injectables market restraint impact
Fig. 16 Global Osteoarthritis Injectables market strategic initiatives analysis
Fig. 17 Global Osteoarthritis Injectables market: Injection Type movement analysis
Fig. 18 Global Osteoarthritis Injectables market: Injection Type outlook and key takeaways
Fig. 19 Hyaluronic Acid Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Corticosteroid Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Platelet-rich Plasma (PRP) Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Placental Tissue Matrix (PTM) Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Acetylsalicylic Acid (ASA) Injections market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Global Osteoarthritis Injectables market: Anatomy movement analysis
Fig. 26 Global Osteoarthritis Injectables market: Anatomy outlook and key takeaways
Fig. 27 Knee Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Hip Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Hand Osteoarthritis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Global Osteoarthritis Injectables market: End-use movement analysis
Fig. 32 Global Osteoarthritis Injectables market: End-use outlook and key takeaways
Fig. 33 Hospital Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Retail Pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Market share of key market players- Global Osteoarthritis Injectables market
Fig. 37 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 38 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 39 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 40 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 41 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 42 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 43 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 44 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 45 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 46 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 47 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 48 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 49 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 50 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 51 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 52 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 53 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 54 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 55 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 56 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 57 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 58 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 59 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
Fig. 60 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 61 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 62 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 63 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
Fig. 64 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
